These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12879167)

  • 1. Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.
    Kukongviriyapan V; Prawan A; Warasiha B; Tassaneyakul W; Aiemsa-ard J
    Eur J Clin Pharmacol; 2003 Aug; 59(4):277-81. PubMed ID: 12879167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population.
    Dhaini HR; Levy GN
    Pharmacogenetics; 2000 Feb; 10(1):79-83. PubMed ID: 10739175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations and polymorphism of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations.
    Zhao B; Lee EJ; Yeoh PN; Gong NH
    Pharmacogenetics; 1998 Aug; 8(4):299-304. PubMed ID: 9731716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population.
    Zhangwei X; Jianming X; Qiao M; Xinhua X
    Clin Chim Acta; 2006 Sep; 371(1-2):85-91. PubMed ID: 16600204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1).
    Bruhn C; Brockmöller J; Cascorbi I; Roots I; Borchert HH
    Biochem Pharmacol; 1999 Dec; 58(11):1759-64. PubMed ID: 10571250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental expression of arylamine N-acetyltransferases: evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2.
    Smelt VA; Mardon HJ; Sim E
    Pharmacol Toxicol; 1998 Oct; 83(4):149-57. PubMed ID: 9820875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility.
    Varzim G; Monteiro E; Silva R; Pinheiro C; Lopes C
    ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):206-12. PubMed ID: 12037388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.
    Prawan A; Kukongviriyapan V; Tassaneeyakul W; Pairojkul C; Bhudhisawasdi V
    Eur J Cancer Prev; 2005 Jun; 14(3):245-50. PubMed ID: 15901993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between NAT1 genotype and phenotype in a Japanese population.
    Yang M; Katoh T; Delongchamp R; Ozawa S; Kohshi K; Kawamoto T
    Pharmacogenetics; 2000 Apr; 10(3):225-32. PubMed ID: 10803678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A restriction fragment length polymorphism assay that differentiates human N-acetyltransferase-1 (NAT1) alleles.
    Deitz AC; Doll MA; Hein DW
    Anal Biochem; 1997 Nov; 253(2):219-24. PubMed ID: 9367506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: implications for cancer predisposition.
    Fretland AJ; Doll MA; Zhu Y; Smith L; Leff MA; Hein DW
    Cancer Detect Prev; 2002; 26(1):10-4. PubMed ID: 12088197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-acetyltransferase 1 and 2 polymorphisms in para-substituted arylamine-induced contact allergy.
    Westphal GA; Reich K; Schulz TG; Neumann C; Hallier E; Schnuch A
    Br J Dermatol; 2000 Jun; 142(6):1121-7. PubMed ID: 10848734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers.
    Abdel-Rahman SZ; El-Zein RA; Zwischenberger JB; Au WW
    Mutat Res; 1998 Feb; 398(1-2):43-54. PubMed ID: 9626964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
    Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
    Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): the identification of two novel allelic variants.
    Payton MA; Sim E
    Biochem Pharmacol; 1998 Feb; 55(3):361-6. PubMed ID: 9484803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase genotypes and the pharmacokinetics and tolerability of para-aminosalicylic acid in patients with drug-resistant pulmonary tuberculosis.
    Sy SK; de Kock L; Diacon AH; Werely CJ; Xia H; Rosenkranz B; van der Merwe L; Donald PR
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4129-38. PubMed ID: 25963985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.